References
- RapidisADGullanePLangdonJDLefebvreJLScullyCShahJPMajor advances in the knowledge and understanding of the epidemiology, aetiopathogenesis, diagnosis, management and prognosis of oral cancerOral Oncol2009454–529930019411038
- ScullyCBaganJOral squamous cell carcinoma overviewOral Oncol2009454–530130819249237
- BozecAPeyradeFFischelJLMilanoGEmerging molecular targeted therapies in the treatment of head and neck cancerExpert Opin Emerg Drugs200914229931019519286
- ScullyCFieldJKTanzawaHGenetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN) – 1: carcinogen metabolism, DNA repair and cell cycle controlOral Oncol200036325626310793327
- BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
- HeLHannonGJMicroRNAs: small RNAs with a big role in gene regulationNat Rev Genet20045752253115211354
- GomesCCGomezRSMicroRNA and oral cancer: future perspectivesOral Oncol2008441091091418620891
- GarzonRCalinGACroceCMMicroRNAs in cancerAnnu Rev Med20096016717919630570
- JiangLYuLZhangXmiR-892b silencing activates NF-κB and promotes aggressiveness in breast cancerCancer Res20167651101111126747895
- HuCHuangFDengGNieWHuangWZengXmiR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1Exp Ther Med2013651265127024223656
- YanBGuoQNanXXMicro-ribonucleic acid 29b inhibits cell proliferation and invasion and enhances cell apoptosis and chemotherapy effects of cisplatin via targeting of DNMT3b and AKT3 in prostate cancerOnco Targets Ther2015855756525784815
- ZhanYXiangFWuRMiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88J Ovarian Res201584826223974
- LiJHuangHSunLMiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitorClin Cancer Res200915123998400819509158
- LiuCJKaoSYTuHFTsaiMMChangKWLinSCIncrease of microRNA miR-31 level in plasma could be a potential marker of oral cancerOral Dis201016436036420233326
- LiuCJTsaiMMHungPSmiR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinomaCancer Res20107041635164420145132
- KozakiKImotoIMogiSOmuraKInazawaJExploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancerCancer Res20086872094210518381414
- SantarpiaLLippmanSMEl-NaggarAKTargeting the MAPK-RAS-RAF signaling pathway in cancer therapyExpert Opin Ther Targets201216110311922239440
- DownwardJTargeting RAS signalling pathways in cancer therapyNat Rev Cancer200331112212509763
- ClarkGJWestwickJKDerCJp120 GAP modulates Ras activation of Jun kinases and transformationJ Biol Chem19972723167716818999845
- StoweIBMercadoELStoweTRA shared molecular mechanism underlies the human rasopathies Legius syndrome and neurofibromatosis-1Genes Dev201226131421142622751498
- CoutinhoCMBassiniASGutierrezLGGenetic alterations in Ki-Ras and Ha-Ras genes in juvenile nasopharyngeal angiofibromas and head and neck cancerSao Paulo Med J1999117311312010511729
- SathyanKMNalinakumariKRKannanSH-Ras mutation modulates the expression of major cell cycle regulatory proteins and disease prognosis in oral carcinomaMod Pathol200720111141114817767136
- SeverinoPBrüggemannHAndreghettoFMMicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferationBMC Cancer20131353324209638
- PriorIALewisPDMattosCA comprehensive survey of Ras mutations in cancerCancer Res201272102457246722589270
- DasNMajumderJDasGuptaUBRas gene mutations in oral cancer in eastern IndiaOral Oncol2000361768010889924
- ChangSEBhatiaPJohnsonNWRas mutations in United Kingdom examples of oral malignancies are infrequentInt J Cancer19914834094122040536
- XuJGimenez-ContiIBCunninghamJEAlterations of p53, cyclin D1, Rb, and H-Ras in human oral carcinomas related to tobacco useCancer19988322042129669801
- SunDYuFMaYMicroRNA-31 activates the RAS pathway and functions as an oncogenic microRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1)J Biol Chem2013288139508951823322774
- SharmaSBLinCCFarrugiaMKMicroRNAs 206 and 21 cooperate to promote RAS-extracellular signal-regulated kinase signaling by suppressing the translation of RASA1 and SPRED1Mol Cell Biol201434224143416425202123
- GuttillaIKWhiteBACoordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cellsJ Biol Chem200928435232042321619574223
- LiPShengCHuangLMiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migrationBreast Cancer Res201416647325394902
- RoaWBrunetBGuoLIdentification of a new microRNA expression profile as a potential cancer screening toolClin Invest Med2010332E12420370992
- ChoWCChowASAuJSRestoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutationEur J Cancer200945122197220619493678
- SeguraMFHannifordDMenendezSAberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factorProc Natl Acad Sci U S A200910661814181919188590
- JiangLMaoPSongLmiR-182 as a prognostic marker for glioma progression and patient survivalAm J Pathol20101771293820472885
- LiuZLiuJSeguraMFMiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinomaJ Pathol2012228220421522322863
- LiuHDuLWenZUp-regulation of miR-182 expression in colorectal cancer tissues and its prognostic valueInt J Colorectal Dis201328569770323474644
- HirataHUenoKShahryariVMicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancerPLoS One201381e5550223383207
- WeeraratneSDAmaniVTeiderNPleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastomaActa Neuropathol2012123453955222402744
- LarramendyMLTarkkanenMBlomqvistCComparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic markerAm J Pathol19971514115311619327749
- ChiangCHHouMFHungWCUp-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECKBiochim Biophys Acta2013183043067307623333633
- PengXLiWYuanLMehtaRGKopelovichLMcCormickDLInhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21PLoS One201388e7044223936432
- RasheedSATeoCRBeillardEJVoorhoevePMCaseyPJMicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cellsJ Biol Chem2013288117986799523329838
- WinstonJTCoatsSRWangYZPledgerWJRegulation of the cell cycle machinery by oncogenic RasOncogene19961211271348552383
- SachdevaMMitoJKLeeCLMicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genesJ Clin Invest2014124104305431925180607